Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 487 for sleep

Edit search filters
  1. A Study To Evaluate Lamprene (Clofazimine) To Treat Non-Tuberculous Mycobacterial (NTM) Infections

    Jacksonville, FL

  2. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of TRK-250 For Patients With Idiopathic Pulmonary Fibrosis

    Jacksonville, FL

  3. A Study To Evaluate Tucatinib And Trastuzumab In Solid Tumors With HER2 Alterations

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study to Compare Non-invasive Near-infrared Spectroscopy (NIRS) to Invasive Licox Intracranial Pressure Monitoring in Neurocritical Care

    Rochester, MN

  5. A Study Of Lebrikizumab In Participants With Idiopathic Pulmonary Fibrosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Radiation Therapy in Treating Patients with Extensive Stage Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma

    Rochester, MN

  8. Plasma Exchange And Glucocorticoids For Treatment Of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

    Rochester, MN

  9. Study Of Pembrolizumab (MK-3475) In Participants With Relapsed Or Refractory Primary Mediastinal Large B-cell Lymphoma Or Relapsed Or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)

    Rochester, MN

  10. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer